These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 21553647)

  • 1. Preparation and characterization of nitrendipine solid lipid nanoparticles.
    Manjunath K; Venkateswarlu V; Hussain A
    Pharmazie; 2011 Mar; 66(3):178-86. PubMed ID: 21553647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles.
    Venkateswarlu V; Manjunath K
    J Control Release; 2004 Mar; 95(3):627-38. PubMed ID: 15023472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics, tissue distribution and bioavailability of nitrendipine solid lipid nanoparticles after intravenous and intraduodenal administration.
    Manjunath K; Venkateswarlu V
    J Drug Target; 2006 Nov; 14(9):632-45. PubMed ID: 17090399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: effects of process variables.
    Das S; Ng WK; Kanaujia P; Kim S; Tan RB
    Colloids Surf B Biointerfaces; 2011 Nov; 88(1):483-9. PubMed ID: 21831615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and evaluation of nitrendipine loaded solid lipid nanoparticles: influence of wax and glyceride lipids on plasma pharmacokinetics.
    Kumar VV; Chandrasekar D; Ramakrishna S; Kishan V; Rao YM; Diwan PV
    Int J Pharm; 2007 Apr; 335(1-2):167-175. PubMed ID: 17161566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration.
    Manjunath K; Venkateswarlu V
    J Control Release; 2005 Oct; 107(2):215-28. PubMed ID: 16014318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of stable nitrendipine nanosuspensions using the precipitation-ultrasonication method for enhancement of dissolution and oral bioavailability.
    Xia D; Quan P; Piao H; Piao H; Sun S; Yin Y; Cui F
    Eur J Pharm Sci; 2010 Jul; 40(4):325-34. PubMed ID: 20417274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and formulation optimization of solid lipid nanoparticles in vitamin K1 delivery.
    Liu CH; Wu CT; Fang JY
    Drug Dev Ind Pharm; 2010 Jul; 36(7):751-61. PubMed ID: 20136495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization.
    Liu J; Gong T; Wang C; Zhong Z; Zhang Z
    Int J Pharm; 2007 Aug; 340(1-2):153-62. PubMed ID: 17428627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and particle matrix structure.
    Kovacevic A; Savic S; Vuleta G; Müller RH; Keck CM
    Int J Pharm; 2011 Mar; 406(1-2):163-72. PubMed ID: 21219990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: characterization.
    Attama AA; Schicke BC; Paepenmüller T; Müller-Goymann CC
    Eur J Pharm Biopharm; 2007 Aug; 67(1):48-57. PubMed ID: 17276663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of SLN and NLC enriched hydrogels for transdermal delivery of nitrendipine: in vitro and in vivo characteristics.
    Bhaskar K; Krishna Mohan C; Lingam M; Jagan Mohan S; Venkateswarlu V; Madhusudan Rao Y; Bhaskar K; Anbu J; Ravichandran V
    Drug Dev Ind Pharm; 2009 Jan; 35(1):98-113. PubMed ID: 18665979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles.
    Vivek K; Reddy H; Murthy RS
    AAPS PharmSciTech; 2007 Oct; 8(4):E83. PubMed ID: 18181544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.
    Dudhipala N; Veerabrahma K
    Drug Deliv; 2016; 23(2):395-404. PubMed ID: 24865287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poly(vinyl alcohol) as emulsifier stabilizes solid triglyceride drug carrier nanoparticles in the alpha-modification.
    Rosenblatt KM; Bunjes H
    Mol Pharm; 2009; 6(1):105-20. PubMed ID: 19049318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Part I: Development and optimization of solid-lipid nanoparticles using Box-Behnken statistical design for ocular delivery of gatifloxacin.
    Abul Kalam M; Sultana Y; Ali A; Aqil M; Mishra AK; Aljuffali IA; Alshamsan A
    J Biomed Mater Res A; 2013 Jun; 101(6):1813-27. PubMed ID: 23255511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization and in vitro assessment of paclitaxel loaded lipid nanoparticles formulated using modified solvent injection technique.
    Pandita D; Ahuja A; Velpandian T; Lather V; Dutta T; Khar RK
    Pharmazie; 2009 May; 64(5):301-10. PubMed ID: 19530440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development, characterization and in vitro assessement of stearylamine-based lipid nanoparticles of paclitaxel.
    Pandita D; Ahuja A; Lather V; Dutta T; Velpandian T; Khar RK
    Pharmazie; 2011 Mar; 66(3):171-7. PubMed ID: 21553646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characterization of ibuprofen solid lipid nanoparticles with enhanced solubility.
    Potta SG; Minemi S; Nukala RK; Peinado C; Lamprou DA; Urquhart A; Douroumis D
    J Microencapsul; 2011; 28(1):74-81. PubMed ID: 21171818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of nitrendipine controlled release formulations based on SLN and NLC for topical delivery: in vitro and ex vivo characterization.
    Bhaskar K; Krishna Mohan C; Lingam M; Prabhakar Reddy V; Venkateswarlu V; Madhusudan Rao Y
    Drug Dev Ind Pharm; 2008 Jul; 34(7):719-25. PubMed ID: 18612912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.